<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30059813</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>05</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1873-264X</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>160</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>25</Day>                    </PubDate>                </JournalIssue>                <Title>Journal of pharmaceutical and biomedical analysis</Title>                <ISOAbbreviation>J Pharm Biomed Anal</ISOAbbreviation>            </Journal>            <ArticleTitle>Metabolic fingerprinting in breast cancer stages through <sup>1</sup>H NMR spectroscopy-based metabolomic analysis of plasma.</ArticleTitle>            <Pagination>                <MedlinePgn>38-45</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0731-7085(18)31211-1</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpba.2018.07.024</ELocationID>            <Abstract>                <AbstractText>Breast cancer (BC) is one of the most common malignancies among women worldwide, which is indeed associated with metabolic reprogramming. However, BC is a very complex and heterogeneous disease, which can relate with the changes in metabolic profiles during BC progression. Hence, investigating the metabolic alterations during BC stage progression may reveal the deregulated pathways and useful metabolic signatures of BC. To demonstrate the metabolic insights, we opted <sup>1</sup>H NMR spectroscopy based metabolomics of blood plasma of early and late stage BC (N = 72) with age and gender matched healthy subjects (N = 50). Further, the metabolic profiles were analyzed to delineate the potential signatures of BC by performing multivariate and nonparametric statistical analysis in early and late stages of BC in comparison with healthy subjects. Sixteen metabolites levels were differentially changed (p &lt; 0.05) in the early and late stages of BC from healthy subjects. Among them, the levels of hydroxybutyrate, lysine, glutamate, glucose, N-acetyl glycoprotein, Lactate were highly distinguished in BC stages and showed a good biomarker potential using receiver-operating curves based diagnostic models. Furthermore, the significant modulation and good diagnostic performances of glutamate, N-acetyl glycoprotein and Lactate in LBC as compared to EBC give their significance in the BC progression. In general, our observations demonstrate that these panels of metabolites may act as vital component of the metabolism of early to late stage BC progression. Our results also open new avenue towards early and late stage BC diagnosis and intervention implying metabolomics approaches.</AbstractText>                <CopyrightInformation>Copyright © 2018. Published by Elsevier B.V.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Suman</LastName>                    <ForeName>Shankar</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Proteomics and Environmental Carcinogenesis Laboratory, Food, Drug and Chemical Toxicology Group, 31 Vishvigyan Bhawan, CSIR-Indian Institute of Toxicology Research, Mahatma Gandhi Marg, Post Box 80, Lucknow, 226001, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-IITR Campus, Lucknow, India.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sharma</LastName>                    <ForeName>Raj Kumar</ForeName>                    <Initials>RK</Initials>                    <AffiliationInfo>                        <Affiliation>Center of Biomedical Research, SGPGIMS-campus, Raibareilly Road, Lucknow, U.P., 226014, India.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kumar</LastName>                    <ForeName>Vijay</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgical Oncology, King George's Medical University, Chowk, Lucknow, 226003, India.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sinha</LastName>                    <ForeName>Neeraj</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Center of Biomedical Research, SGPGIMS-campus, Raibareilly Road, Lucknow, U.P., 226014, India.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shukla</LastName>                    <ForeName>Yogeshwer</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Proteomics and Environmental Carcinogenesis Laboratory, Food, Drug and Chemical Toxicology Group, 31 Vishvigyan Bhawan, CSIR-Indian Institute of Toxicology Research, Mahatma Gandhi Marg, Post Box 80, Lucknow, 226001, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-IITR Campus, Lucknow, India. Electronic address: yshukla@iitr.res.in.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>18</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>J Pharm Biomed Anal</MedlineTA>            <NlmUniqueID>8309336</NlmUniqueID>            <ISSNLinking>0731-7085</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">(1)H NMR spectroscopy</Keyword>            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Glutamate</Keyword>            <Keyword MajorTopicYN="N">Lactate</Keyword>            <Keyword MajorTopicYN="N">Metabolomics</Keyword>            <Keyword MajorTopicYN="N">N-acetyl glycoprotein</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>22</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>15</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>7</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>7</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>7</Month>                <Day>31</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30059813</ArticleId>            <ArticleId IdType="pii">S0731-7085(18)31211-1</ArticleId>            <ArticleId IdType="doi">10.1016/j.jpba.2018.07.024</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>